ArticleCureus2025
Thyroid Nodule Management and Compliance With Guidelines in a District General Hospital in London: A Retrospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThyroid nodules affect a small number of adults. Progress has been made to streamline and create a structured approach for evaluating and managing thyroid nodules, such as the use of ultrasound (US) U-scores (U1-U5) to stratify risk and guide the need for fine needle aspiration cytology (FNAC). This audit aimed to evaluate the adherence to the British Thyroid Association (BTA) 2014 guidelines in local practice at our local hospital.
methodsThis retrospective audit included 50 thyroid US reports over 12 months, identifying nodules and assessing compliance with BTA 2014 guidelines. Reports were evaluated for inclusion of a U-score or equivalent classification, such as the Thyroid Imaging Reporting and Data System score. Four patients did not have a U-score provided initially, which was retrospectively assigned by a consultant radiologist. FNAC performance was assessed based on U-score risk stratification: FNAC was expected for U3-U5 nodules, not U1 and U2. Cytology results were reviewed and classified using the THY system. The audit also analyzed reasons for deviation from guidelines by reviewing patients' medical notes for any documented reasons and the outcomes of histological analysis where surgical intervention occurred.
resultsOf the 50 US reports reviewed, 49 (98%) included a U-score. Distribution was as follows: U2 (13 cases), U3 (18 cases), U2/U3 (12 cases), U4 (five cases), and U3/U4 (one case). FNAC was indicated in 37 cases based on the U-score and was performed in 31. Despite being shown, six instances did not receive FNAC, often due to valid clinical reasons such as comorbidities, patient refusal, or alternative diagnoses. A total of 28 cases were classified cytologically using the THY system: THY 1 (one case), THY 2 (nine cases), THY 2c (one case), THY 3 (one case), THY 3A (seven cases), THY 3F (six cases), mixed THY 2/3 (one case), and THY 4 (two cases). Two cases had indeterminate THY 3 cytology, and one FNAC attempt was unsuccessful due to vascularity. Among the 31 cases assessed via FNAC, five were diagnosed with malignancy; four underwent hemithyroidectomy, and one had a local excision. Additionally, three patients who had hemithyroidectomy were found to have benign adenomas, most commonly follicular adenomas. Overall, 80% of cases adhered to BTA guidelines regarding FNAC indication. All U2 and U4 cases were managed in accordance with guidelines.
conclusionThis audit demonstrates high compliance with the BTA 2014 guidelines, with near-universal documentation of U-scores and appropriate use of FNAC in most cases. While deviations were minimal and often clinically justified, there remains scope to improve standardization and adherence through targeted education and resource support. Continued emphasis on guideline-driven practice is essential to ensure optimal management of thyroid nodules and efficient use of clinical resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.